Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001127602-23-006511

EVP R&D, Chief Medical Officer gave up 16,015 shares (to pay taxes)

  • EVP R&D, Chief Medical Officer acquired 22,195 shares (grant or award)
  • EVP R&D, Chief Medical Officer acquired 25,692 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hopkinson Craig C. · EVP R&D, Chief Medical Officer

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-18 Exercise or conversion : show line 1 in the form +8,722 26,716 D
2023-02-18 Shares withheld for taxes : show line 2 in the form −2,656 $28.07 $74,554 24,060 D
2023-02-20 Exercise or conversion : show line 3 in the form +10,095 34,155 D
2023-02-20 Shares withheld for taxes : show line 4 in the form −3,780 $28.07 $106,105 30,375 D
2023-02-20 Grant or award : show line 5 in the form +22,195 52,570 D
2023-02-20 Shares withheld for taxes : show line 6 in the form −6,526 $28.07 $183,185 46,044 D
2023-02-21 Exercise or conversion : show line 7 in the form +6,875 52,919 D
2023-02-21 Shares withheld for taxes : show line 8 in the form −3,053 $27.77 $84,782 49,866 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2023-02-18 Exercise or conversion : show line 9 in the form Restricted Stock Unit Award −8,722 26,167 D
2023-02-20 Exercise or conversion : show line 10 in the form Restricted Stock Unit Award −10,095 10,096 D
2023-02-21 Exercise or conversion : show line 11 in the form Restricted Stock Unit Award −6,875 0 D
Loading xslF345X03/form4.xml…